Provectus Biopharmaceuticals, Inc. (PVCT): Cash & Equivalents
$251.3K
As of 2025-12-31
$1.16M
As of 2026-06-30
+126.6%
3-year compound annual growth
+20.9%
5-year compound annual growth
-33.2%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $251.3K | -18.3% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $307.4K | +301.5% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $76.6K | +254.4% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $21.6K | -96.8% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $683.0K | +602.4% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $97.2K | -83.5% | 2022-03-29, Balance as of period end |
| 2019-12-31 | $590.7K | n/m | 2021-03-02, Balance as of period end |
| 2018-12-31 | $51.0K | -51.7% | 2020-03-05, Balance as of period end |
| 2017-12-31 | $105.5K | -90.9% | 2019-03-07, Balance as of period end |
| 2016-12-31 | $1.17M | -91.8% | 2018-03-23, Balance as of period end |
| 2015-12-31 | $14.18M | -18.5% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $17.39M | +10.8% | 2017-03-31, Balance as of period end |
| 2013-12-31 | $15.70M | n/m | 2016-03-30, Balance as of period end |
| 2012-12-31 | $1.22M | -84.1% | 2015-03-12, Balance as of period end |
| 2011-12-31 | $7.71M | -4.7% | 2014-03-13, Balance as of period end |
| 2010-12-31 | $8.09M | +149.8% | 2014-03-13, Balance as of period end |
| 2009-12-31 | $3.24M | +15.8% | 2013-03-14, Balance as of period end |
| 2008-12-31 | $2.80M | n/a | 2012-03-14, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $251.3K | -18.3% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $14.69M | -24.8% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $4.98M | n/m |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $681.5K | +174.4% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $5.53M | +14.6% |
| Medicinova Inc (MNOV) | 2025-12-31 | $30.81M | -23.7% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $6.66M | n/a |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $69.6K | n/m |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $40.99M | -41.3% |
Compare PVCT, ALLR, HIND, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗